Optimization Academy with Dr. Greg Jones
Optimization Academy with Dr. Greg Jones
Dr. Greg Jones
95. Orforglipron Explained: The New Oral GLP-1 for Weight Loss
56 minutes Posted Aug 26, 2026 at 9:00 am.
04:27)The evolution of longevity medicine (04:27 - 06:39)Understanding orforglipron as a new molecule (06:39 - 08:08)Bioavailability and absorption: small molecules vs. peptides (08:08 - 13:21)Clinical implications of orforglipron (13:21 - 16:48)Weight loss and patient expectations (16:48 - 20:45)Secondary benefits and cardiovascular health (20:45 - 24:49)Contraception considerations with orforglipron (24:49 - 29:17)Understanding GLP-1 and its implications (29:17 - 30:14)Surgical considerations with GLP-1 medications (30:14 - 33:39)Muscle preservation and management on GLP-1s (33:39 - 40:33)Integrating GLP-1s into hormone optimization protocols (40:33 - 45:30)Cost and accessibility of GLP-1 medications (45:30 - 49:53)Conclusions and future directions for GLP-1s (49:53 - 56:10)
0:00
56:12
Download MP3
Show notes
Orforglipron is a new oral GLP-1 medication for weight loss, and many patients are asking how it compares to injectable options like Ozempic, Wegovy, and Zepbound. In this episode, Dr. Greg Jones is joined by Dr. Kris Wusterhausen to explain what orforglipron is, how it works, and where it may fit in the future of medical weight management.They discuss why this oral GLP-1 is different from traditional peptide-based therapies, including how small-molecule medications may affect absorption, dosing convenience, and patient accessibility. The conversation also covers what current research shows about weight-loss results, blood sugar changes, cardiovascular markers, side effects, contraception considerations, surgical precautions, and long-term use.If you are curious about orforglipron, oral GLP-1 medications, weight-loss drugs, metabolic health, muscle preservation, or how these therapies compare with injectable GLP-1 options, this episode offers a practical, clinically informed overview of the benefits, limitations, and unanswered questions.Get 10% off your first order at Dr. Jones Supplement Store when you join the email list. https://drjonessupplements.com/📌 About Dr. Kris WusterhausenDr. Kris Wusterhausen, DO, is a board-certified Family Medicine physician and founder of The Resurge Clinic in Weatherford, Texas. For nearly two decades, he has focused on hormone optimization, metabolic health, weight management, peptide therapy, and longevity medicine.In addition to caring for patients, Dr. Wusterhausen serves as Medical Director of the BioTE Training Clinic, where he helps educate healthcare providers on advanced approaches to preventive and age-management medicine. He is also a nationally recognized speaker who regularly lectures on hormones, peptides, body composition, and long-term health optimization.📌Learn More About Dr. Kris WusterhausenWebsite: https://www.theresurgeclinic.com/About Dr. Kris: https://www.theresurgeclinic.com/about/Facebook: https://www.facebook.com/theresurgeclinic/YouTube: https://www.youtube.com/playlist?list=PLPZhIf03cd8xu7_CKwAc41vdpeUEQMtem📌Connect with Dr. Greg JonesBook Dr. Jones to speak at your next event: https://www.drjonesnmd.com/Enovative Wellness Center: https://enovativewellness.com/Instagram: https://www.instagram.com/doctorjones_doctorjones/Facebook: https://www.facebook.com/GregJonesNMDYouTube: https://www.youtube.com/@DrGregJonesNMDSpotify: https://open.spotify.com/show/2QrMGwCIGo1kjdezfCyYDK🔗 Want to learn more? Check these resources:• FDA Prescribing Information – Foundayo/orforglipron: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf • Lilly – Foundayo/orforglipron FDA Approval Announcement: https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill • Daily oral orforglipron for adults with obesityhttps://pubmed.ncbi.nlm.nih.gov/37351564/ • Oral orforglipron for type 2 diabetes, HbA1c, and body weighthttps://pubmed.ncbi.nlm.nih.gov/37369232/ 🔬 TimestampsIntroduction and recap of previous episodes (00:00 - 04:27)The evolution of longevity medicine (04:27 - 06:39)Understanding orforglipron as a new molecule (06:39 - 08:08)Bioavailability and absorption: small molecules vs. peptides (08:08 - 13:21)Clinical implications of orforglipron (13:21 - 16:48)Weight loss and patient expectations (16:48 - 20:45)Secondary benefits and cardiovascular health (20:45 - 24:49)Contraception considerations with orforglipron (24:49 - 29:17)Understanding GLP-1 and its implications (29:17 - 30:14)Surgical considerations with GLP-1 medications (30:14 - 33:39)Muscle preservation and management on GLP-1s (33:39 - 40:33)Integrating GLP-1s into hormone optimization protocols (40:33 - 45:30)Cost and accessibility of GLP-1 medications (45:30 - 49:53)Conclusions and future directions for GLP-1s (49:53 - 56:10)